InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Ori Gutwerg
10 Aug 2026
SVP, Generics
Sell
3,162
$77.00
$243.47K
Patrick D Walsh
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Ori Gutwerg
12 May 2026
SVP, Generics
Sell
2,772
$79.50
$220.37K
Thomas Andrew Rowland
12 May 2026
SVP, Head - Established Brands
Sell
459
$79.21
$36.36K
Nikhil Lalwani
11 May 2026
President & CEO
Sell
55,000
$77.57
$4.27M
Patrick D Walsh
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Thomas Andrew Rowland
11 Mar 2026
SVP, Head - Established Brands
Sell
4,772
$74.91
$357.47K
Patrick D Walsh
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Ori Gutwerg
3 Mar 2026
SVP, Generics
Sell
2,060
$76.50
$157.59K
Renee P Tannenbaum
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Chad Gassert
13 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
94
$88.00
$8.27K
Patrick D Walsh
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Chad Gassert
12 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
14,642
$89.07
$1.30M
Show all 50 transactions →

What was left out

Form 4 filings counted 77
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 389,730
History held since 29 Sep 2006